Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Rilonacept: Overview, Related Topics & Entities

Rilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle–Wells syndrome; deficiency of interleukin-1 receptor antagonist; and recurrent pericarditis. Rilonacept is an interleukin 1 inhibitor.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Rilonacept topic overview

The analysis highlights Overview, Related Topics and Entities as prominent areas in the source structure around Rilonacept.

Related topics
12
Source areas
1
Connected nodes
13
Extracted relationships
24
Concept neighborhoods
13
Bridge connections
13

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 12 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

AHFS/Drugs.com
Monograph
ATC code
L04AC04 (WHO)
CAS Number
501081-76-1 Y
ChEMBL
ChEMBL1201830 N
ChemSpider
none
DrugBank
DB06372 Y

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Rilonacept connects Entity context

The extracted context around Rilonacept shows recurring relationship patterns in the source. For example, Rilonacept → Archived, Drug Information Portal, January, Medicine, National Library Another extracted example is Rilonacept → EU: Rx-only, US: ℞-only. Use these groups to spot repeated connection types before inspecting the individual relationships.

Rilonacept

Top relations

related to External links · 5
Rilonacept → Archived, Drug Information Portal, January, Medicine, National Library
Legal status · 2
Rilonacept → EU: Rx-only, US: ℞-only
License data · 2
Rilonacept → EU EMA: by INN, US DailyMed: Rilonacept
is a · 2
Rilonacept → first drug approved by the FDA to treat recurrent pericarditis, interleukin 1 inhibitor.Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellular portions of the human interleukin-1 receptor component
AHFS/Drugs.com · 1
Rilonacept → Monograph
ATC code · 1
Rilonacept → L04AC04 (WHO)
CAS Number · 1
Rilonacept → 501081-76-1 Y
ChEMBL · 1
Rilonacept → ChEMBL1201830 N
ChemSpider · 1
Rilonacept → none
DrugBank · 1
Rilonacept → DB06372 Y

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

drug fda pericarditis used treat cryopyrin-associated periodic syndromes including familial cold autoinflammatory syndrome muckle wells interleukin-1 receptor recurrent treatment approved

Rilonacept relationships Subject–Predicate–Object triples

TTTA extracted 24 structured relationships around Rilonacept. Examples in this analysis include Rilonacept → AHFS/Drugs.com → Monograph and Rilonacept → ATC code → L04AC04 (WHO). The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
RilonaceptAHFS/Drugs.comMonograph1.00infobox
RilonaceptATC codeL04AC04 (WHO)1.00infobox
RilonaceptCAS Number501081-76-1 Y1.00infobox
RilonaceptChEMBLChEMBL1201830 N1.00infobox
RilonaceptChemSpidernone1.00infobox
RilonaceptDrugBankDB06372 Y1.00infobox
RilonaceptFormulaC9030H13932N2400O2670S741.00infobox
RilonaceptKEGGD066351.00infobox
RilonaceptLegal statusUS: ℞-only1.00infobox
RilonaceptLegal statusEU: Rx-only1.00infobox
RilonaceptLicense dataEU EMA: by INN1.00infobox
RilonaceptLicense dataUS DailyMed: Rilonacept1.00infobox
RilonaceptMolar mass201209.36 g·mol−11.00infobox
RilonaceptOther namesIL-1 Trap1.00infobox
RilonaceptRoutes of administrationSubcutaneous1.00infobox
RilonaceptTrade namesArcalyst1.00infobox
RilonaceptUNII8K80YB5GMG1.00infobox
Rilonaceptis ainterleukin 1 inhibitor.Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellular portions of the human interleukin-1 receptor component0.90text
Rilonaceptis afirst drug approved by the FDA to treat recurrent pericarditis0.90text

Related concept clusters Concept neighborhoods

The concept neighborhoods around Rilonacept bring nearby vocabulary together. In this analysis, examples include Drug, Approved and Arcalyst. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Rilonacept
    • Drug
    • Approved
    • Arcalyst
    • Il-1
    • Interleukin-1
    • Pericarditis
    • Receptor
    • Recurrent
    • Treat
    • Fda
    • Antagonist
    • Brand
  • rilonacept
    • Drug
    • Approved
    • Arcalyst
    • Il-1
    • Interleukin-1
    • Pericarditis
    • Receptor
    • Recurrent
    • Treat
    • Fda
    • Antagonist
    • Brand
  • cryopyrin-associated periodic syndromes
    • Autoinflammatory
    • Cold
    • Familial
    • Including
    • Muckle
    • Periodic
    • Syndrome
    • Syndromes
    • Used
    • Wells
    • Antagonist
    • Deficiency
  • familial cold autoinflammatory syndrome
    • Autoinflammatory
    • Cold
    • Cryopyrin-associated
    • Familial
    • Including
    • Muckle
    • Periodic
    • Syndrome
    • Syndromes
    • Used
    • Wells
    • Antagonist
  • muckle–wells syndrome
    • Autoinflammatory
    • Cold
    • Cryopyrin-associated
    • Familial
    • Including
    • Muckle
    • Periodic
    • Syndrome
    • Syndromes
    • Used
    • Wells
    • Antagonist
  • interleukin-1 receptor antagonist
    • Brand
    • Deficiency
    • Medication
    • Name
    • Receptor
    • Sold
    • Antagonist
    • Arcalyst
    • Consisting
    • Dimeric
    • Domains
    • Extracellular
  • food and drug administration
    • Fda
    • Treatment
    • Arcalyst
    • Autoinflammatory
    • Cold
    • Cryopyrin-associated
    • Familial
    • Il-1
    • Including
    • Muckle
    • Periodic
    • Syndrome
  • medication
    • Antagonist
    • Deficiency
    • Name
    • Sold
    • Autoinflammatory
    • Cold
    • Cryopyrin-associated
    • Familial
    • Including
    • Interleukin-1
    • Muckle
    • Pericarditis

Connections between topic areas Semantic bridges

Bridges highlight paths between different parts of the Rilonacept map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Map overview Semantic statistics

Rilonacept

Nodes14
Edges13
Triples24
Avg. degree1.86
Density0.142857
Components1

Source & methodology

TTTA analyzes the structure around Rilonacept to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Overview, Related Topics & Entities, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Rilonacept · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.